The effect of cisplatin dose administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

被引：2
|
作者：
Loong, H. H. F.
Ma, B.
Mo, F.
Leung, S. F.
Hui, E. P.
Kam, M. K.
Chan, S. L.
Chan, A. T. C.
机构：
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Clin Oncol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China
[4] CUHK, Sir YK Pao Ctr Canc, Hong Kong Canc Inst, Shatin, Hong Kong, Peoples R China
[5] CUHK, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5532
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
    Loong, Herbert H.
    Ma, Brigette B. Y.
    Leung, Sing-Fai
    Mo, Frankie
    Hui, Edwin P.
    Kam, Michael K.
    Chan, Stephen L.
    Yu, Brian K. H.
    Chan, Anthony T. C.
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 (03) : 300 - 304
  • [2] Individualized cumulative cisplatin dose for locoregionally-advanced nasopharyngeal carcinoma patients receiving induction chemotherapy and concurrent chemoradiotherapy
    Wen, Dan-Wan
    Li, Zhi-Xuan
    Chen, Fo-Ping
    Lin, Li
    Peng, Bin-ying
    Kou, Jia
    Zheng, Wei-Hong
    Yang, Xing-Li
    Xu, Si-Si
    Sun, Ying
    Zhou, Guan-Qun
    ORAL ONCOLOGY, 2020, 107
  • [3] Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma
    Chen, Lin
    Li, Kunpeng
    Li, Qingjie
    Ji, Pengjie
    Huang, Chenglong
    Tang, Linglong
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [4] Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma
    Gu, Mo-Fa
    Liu, Li-Zhi
    He, Long-Jun
    Yuan, Wen-Xin
    Zhang, Rong
    Luo, Guang-Yu
    Xu, Guo-Liang
    Zhang, Hua-Man
    Yan, Chao-Xian
    Li, Jian-Jun
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (01) : 215 - 223
  • [5] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Feng, Hui-Xia
    Guo, Su-Ping
    Li, Gui-Rong
    Zhong, Wen-Huan
    Chen, Liu
    Huang, Li-Ru
    Qin, Hui-Ying
    MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 6
  • [6] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Hui-Xia Feng
    Su-Ping Guo
    Gui-Rong Li
    Wen-Huan Zhong
    Liu Chen
    Li-Ru Huang
    Hui-Ying Qin
    Medical Oncology, 2014, 31
  • [7] Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A SecondaryAnalysis of a Prospective Phase III Clinical Trial
    Peng, Hao
    Chen, Lei
    Zhang, Yuan
    Li, Wen-Fei
    Mao, Yan-Ping
    Zhang, Fan
    Guo, Rui
    Liu, Li-Zhi
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    ONCOLOGIST, 2016, 21 (11): : 1369 - 1376
  • [8] Induction and concurrent chemoradiotherapy with cetuximab for patients with locally advanced nasopharyngeal carcinoma.
    Ho, G. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Weekly docetaxel concurrent chemoradiotherapy versus cisplatin in locoregionally advanced nasopharyngeal carcinoma: A propensity matched analysis
    Liao, J. F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma
    Yu, Hong-Sheng
    Wang, Xin
    Song, Ai-Qin
    Liu, Ning
    Zhang, Wei
    Yu, Li
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3961 - 3965
12345